Laurence Reid, SVP, Chief Business Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 13,500 shares at $67.80 ($909K) on 2014-08-18, disclosed to the SEC on 2014-08-20.
Scheduled sale ($909k) by SVP, Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $66.83 | 6,500 | $434K | 47.8% |
| 2 | $67.80 | 7,000 | $475K | 52.2% |
| Total | $67.33 avg | 13,500 | $909K | 100% |
| Filing → |
| ALNY | SELL | 2014-11-19 | $907K | — | Filing → |
| ALNY | SELL | 2014-05-21 | $781K | — | Filing → |
| ALNY | SELL | 2014-02-20 | $1.6M | — | Filing → |